2-FDCK

2-FDCK je disociatívny arylcyklohexylamin používaný vo výskume antagonizmu NMDA receptorov. Táto zlúčenina je rozsiahle študovaná pre svoje disociatívne anestetické vlastnosti a neurofarmakologické aplikácie.

The history of 2-FDCK is linked to the development of dissociative anesthetics, beginning with the discovery of phencyclidine (PCP) in 1926 and ketamine in 1962. These compounds revealed that NMDA receptor antagonism could produce unique dissociative states distinct from other classes of psychoactive substances. 2-FDCK represents a continuation of research into this pharmacological mechanism. Research into arylcyclohexylamine and related dissociatives intensified in recent decades as scientists sought to understand the relationship between molecular structure and NMDA receptor binding affinity. 2-FDCK emerged as a compound of interest for studying dissociative mechanisms, anesthetic properties, and neuroprotective effects. The compound has been characterized using advanced analytical techniques including mass spectrometry and nuclear magnetic resonance spectroscopy. Modern research utilizing 2-FDCK focuses on understanding NMDA receptor pharmacology, glutamatergic neurotransmission, and potential therapeutic applications. The compound serves as a valuable reference standard in forensic toxicology and analytical chemistry, contributing to the development of detection methods for novel dissociatives in biological samples.

2-FDCK acts as an NMDA (N-methyl-D-aspartate) receptor antagonist, blocking glutamate neurotransmission. This mechanism produces characteristic dissociative effects and makes it valuable for studying glutamatergic system function.

2-FDCK holds significant value in scientific research due to its well-characterized properties and legal accessibility in several jurisdictions. This enables comprehensive pharmacological studies and analytical method development.

High-purity 2-FDCK (≥98% by HPLC) serves as a crucial reference standard in research laboratories, quality control testing, and academic research settings. Its consistent quality makes it ideal for method development and validation.